Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Human Papillomavirus | Research article

Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women

Authors: Amitis Ramezani, Arezoo Aghakhani, Sepehr Soleymani, Anahita Bavand, Azam Bolhassani

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Among different types of human papillomavirus (HPV), types 16 and 18 were known to be high-risk agents causing mainly cervical cancer. Up to now, the potential of HPV E7 protein has been proved as a diagnostic marker of cervical cancer. Moreover, the levels of anti-heat shock protein (Hsp) and anti-high mobility group box-1 (HMGB1) antibodies in cancer patients have been useful in tumor diagnosis. The goal of the present study was to determine the efficiency of the potential serologic markers including HPV E7, Hsp20, Hsp27 proteins and Hp91 peptide in Iranian HPV-exposed women, for the first time.

Methods

At first, the recombinant HPV E7, Hsp20 and Hsp27 proteins were expressed in E. coli system, and purified by affinity chromatography under native conditions. Then, antibody responses were detected against the recombinant proteins as well as Hp91 peptide as potential markers in 49 Iranian women who were seropositive for HPV-16 and 18 L1 capsids (i.e., HPV-exposed women) and 49 controls using indirect ELISA.

Results

Our data indicated that the seroreactivities of women exposed to HPV16, HPV18 and both of them against the recombinant E7, Hsp20, Hsp27 proteins and Hp91 peptide were significantly higher than those in control group (p < 0.05 for HPV16 or HPV18; p < 0.01 for both of them versus all markers). HPV-exposed women with high antibody responses to HPV-16 and 18 L1 capsids as a commercial biomarker had significant seroreactivity to HPV-16 and 18 E7 and Hsp27 (p < 0.05). The recombinant E7 and Hsp27 proteins showed higher efficiency than Hsp20 and Hp91 for detection of individuals exposed to HPV infections (p < 0.05).

Conclusion

Generally, the levels of serum E7 and Hsp27 were increased in HPV-16 and 18 L1- seropositive women suggesting their potential value as a diagnostic marker for HPV infections.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. BMC Cancer. 2016;16:852.PubMedPubMedCentralCrossRef Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. BMC Cancer. 2016;16:852.PubMedPubMedCentralCrossRef
2.
go back to reference Muhr LSA, Eklund C, Dillner J. Towards quality and order in human papillomavirus research. Virology. 2018;519:74–6.PubMedCrossRef Muhr LSA, Eklund C, Dillner J. Towards quality and order in human papillomavirus research. Virology. 2018;519:74–6.PubMedCrossRef
3.
go back to reference Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Mena M. Human papillomavirus and related diseases in the world. Summary Report 27 July 2017. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2017; 1–325. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Mena M. Human papillomavirus and related diseases in the world. Summary Report 27 July 2017. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2017; 1–325.
4.
go back to reference Inan H, Wang S, Inci F, Baday M, Zangar R, Kesiraju S, Anderson KS, Cunningham BT, Demirci U. Isolation, detection, and quantification of cancer biomarkers in HPV-associated malignancies. Sci Rep. 2017;7:1–11.CrossRef Inan H, Wang S, Inci F, Baday M, Zangar R, Kesiraju S, Anderson KS, Cunningham BT, Demirci U. Isolation, detection, and quantification of cancer biomarkers in HPV-associated malignancies. Sci Rep. 2017;7:1–11.CrossRef
5.
go back to reference Nalliah S, Karikalan B, Kademane K. Multifaceted usage of HPV related tests and products in the management of cervical cancer: a review. Asian Pac J Cancer Prev. 2015;16(6):2145–50.PubMedCrossRef Nalliah S, Karikalan B, Kademane K. Multifaceted usage of HPV related tests and products in the management of cervical cancer: a review. Asian Pac J Cancer Prev. 2015;16(6):2145–50.PubMedCrossRef
6.
go back to reference Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehde K. Cost-effectiveness of different cervical screening strategies in Islamic Republic of Iran: a middle-income country with a low incidence rate of cervical cancer. PLoS One. 2016;11(6):e0156705.PubMedPubMedCentralCrossRef Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehde K. Cost-effectiveness of different cervical screening strategies in Islamic Republic of Iran: a middle-income country with a low incidence rate of cervical cancer. PLoS One. 2016;11(6):e0156705.PubMedPubMedCentralCrossRef
7.
go back to reference Ewaisha R, Panicker G, Maranian P, Unger ER, Anderson KS. Serum immune profiling for early detection of cervical disease. Theranostics. 2017;7(16):3814–23.PubMedPubMedCentralCrossRef Ewaisha R, Panicker G, Maranian P, Unger ER, Anderson KS. Serum immune profiling for early detection of cervical disease. Theranostics. 2017;7(16):3814–23.PubMedPubMedCentralCrossRef
8.
go back to reference Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME. Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169:235–40.PubMedCrossRef Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME. Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169:235–40.PubMedCrossRef
9.
go back to reference Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365–71.CrossRef Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365–71.CrossRef
10.
go back to reference Schulze MH, Völker FM, Lugert R, Cooper P, Hasenclever K, Groß U, Pfister H, Silling S. High prevalence of human papillomaviruses in Ghanaian pregnant women. Med Microbiol Immunol. 2016;205(6):595–602.PubMedCrossRef Schulze MH, Völker FM, Lugert R, Cooper P, Hasenclever K, Groß U, Pfister H, Silling S. High prevalence of human papillomaviruses in Ghanaian pregnant women. Med Microbiol Immunol. 2016;205(6):595–602.PubMedCrossRef
11.
go back to reference Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958–64.PubMedCrossRef Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958–64.PubMedCrossRef
12.
13.
go back to reference Yim EK, Park JS. Biomarkers in cervical cancer. Biomark Insights. 2006;1:215–25.CrossRef Yim EK, Park JS. Biomarkers in cervical cancer. Biomark Insights. 2006;1:215–25.CrossRef
14.
go back to reference Chai RC, Lambie D, Verma M, Punyadeera C. Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer Medicine. 2015;4(4):596–607.PubMedPubMedCentralCrossRef Chai RC, Lambie D, Verma M, Punyadeera C. Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer Medicine. 2015;4(4):596–607.PubMedPubMedCentralCrossRef
15.
go back to reference Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. BioMed Res Intl. 2013;2013:1-10. Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. BioMed Res Intl. 2013;2013:1-10.
16.
go back to reference Bolhassani A, Zahedifard F, Taslimi Y, Taghikhani M, Nahavandian B, Rafati S. Antibody detection against HPV16E7 and Gp96 fragments as biomarkers in cervical cancer patients. Indian J Med Res. 2009;130:533–41.PubMed Bolhassani A, Zahedifard F, Taslimi Y, Taghikhani M, Nahavandian B, Rafati S. Antibody detection against HPV16E7 and Gp96 fragments as biomarkers in cervical cancer patients. Indian J Med Res. 2009;130:533–41.PubMed
17.
go back to reference Combes JD, Pawlita M, Waterboer T, Hammouda D, Rajkumar T, Vanhems P, Snijders P, Herrero R, Franceschi S, Clifford G. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer. 2014;135:2453–61.PubMedCrossRef Combes JD, Pawlita M, Waterboer T, Hammouda D, Rajkumar T, Vanhems P, Snijders P, Herrero R, Franceschi S, Clifford G. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer. 2014;135:2453–61.PubMedCrossRef
18.
go back to reference Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res. 2012;72(19):1–10.CrossRef Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res. 2012;72(19):1–10.CrossRef
19.
go back to reference Kuppusamy P, Govindan N, Yusoff MM, Ichwan SJA. Proteins are potent biomarkers to detect colon cancer progression. Saudi Journal of Biological Sciences. 2014:1–10. Kuppusamy P, Govindan N, Yusoff MM, Ichwan SJA. Proteins are potent biomarkers to detect colon cancer progression. Saudi Journal of Biological Sciences. 2014:1–10.
20.
go back to reference Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10(2):86–103.PubMedPubMedCentralCrossRef Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10(2):86–103.PubMedPubMedCentralCrossRef
21.
go back to reference Bolhassani A, Rafati S. Heat-shock proteins as powerful weapons in vaccine development. Expert Rev Vaccines. 2008;7(8):1185–99.PubMedCrossRef Bolhassani A, Rafati S. Heat-shock proteins as powerful weapons in vaccine development. Expert Rev Vaccines. 2008;7(8):1185–99.PubMedCrossRef
22.
go back to reference Basha E, O'Neill H, Vierling E. Small heat shock proteins and alpha-crystallins: dynamic proteins with flexible functions. Trends Biochem Sci. 2012;37(3):106–17.PubMedCrossRef Basha E, O'Neill H, Vierling E. Small heat shock proteins and alpha-crystallins: dynamic proteins with flexible functions. Trends Biochem Sci. 2012;37(3):106–17.PubMedCrossRef
23.
go back to reference Bakthisaran R, Tangirala R, Rao CM. Small heat shock proteins: role in cellular functions and pathology. Biochim Biophys Acta. 2015;1854(4):291–319.PubMedCrossRef Bakthisaran R, Tangirala R, Rao CM. Small heat shock proteins: role in cellular functions and pathology. Biochim Biophys Acta. 2015;1854(4):291–319.PubMedCrossRef
24.
25.
go back to reference Shekhawat SD, Purohit HJ, Taori GM, Daginawala HF, Kashyap RS. Evaluation of host Hsp(s) as potential biomarkers for the diagnosis of tuberculous meningitis. Clin Neurol Neurosurg. 2016;140:47–51.PubMedCrossRef Shekhawat SD, Purohit HJ, Taori GM, Daginawala HF, Kashyap RS. Evaluation of host Hsp(s) as potential biomarkers for the diagnosis of tuberculous meningitis. Clin Neurol Neurosurg. 2016;140:47–51.PubMedCrossRef
26.
go back to reference Mahgoub S, Youns M, Bassyouni A, Hassan Z. Serum levels of heat shock protein 27 as a potential marker of diabetic nephropathy in Egyptians with type 2 diabetes. Journal of Applied Pharmaceutical Science. 2012;2(11):014–20. Mahgoub S, Youns M, Bassyouni A, Hassan Z. Serum levels of heat shock protein 27 as a potential marker of diabetic nephropathy in Egyptians with type 2 diabetes. Journal of Applied Pharmaceutical Science. 2012;2(11):014–20.
27.
28.
go back to reference Ying S, Jiang Z, He X, Yu M, Chen R, Chen J, Ru G, Chen Y, Chen W, Zhu L, Li T, Zhang Y, Guo X, Yin X, Zhang X, Lou J. Serum HMGB1 as a potential biomarker for patients with asbestos-related diseases. Hindawi Disease Markers. 2017:1–9. Ying S, Jiang Z, He X, Yu M, Chen R, Chen J, Ru G, Chen Y, Chen W, Zhu L, Li T, Zhang Y, Guo X, Yin X, Zhang X, Lou J. Serum HMGB1 as a potential biomarker for patients with asbestos-related diseases. Hindawi Disease Markers. 2017:1–9.
29.
go back to reference Harris HE, Andersson U. The nuclear protein HMGB1 as a pro-inflammatory mediator. Eur J Immunol. 2004;34:1503–12.CrossRef Harris HE, Andersson U. The nuclear protein HMGB1 as a pro-inflammatory mediator. Eur J Immunol. 2004;34:1503–12.CrossRef
30.
go back to reference Gnanasekar M, Kalyanasundaram R, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A. HMGB1: a promising therapeutic target for prostate cancer. Hindawi Publishing Corporation, Prostate Cancer. 2013:1–8. Gnanasekar M, Kalyanasundaram R, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A. HMGB1: a promising therapeutic target for prostate cancer. Hindawi Publishing Corporation, Prostate Cancer. 2013:1–8.
31.
go back to reference Saenz R, Souza Cda S, Huang CT, Larsson M, Esener S, Messmer D. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen. Vaccine. 2010;28:7556–62.PubMedPubMedCentralCrossRef Saenz R, Souza Cda S, Huang CT, Larsson M, Esener S, Messmer D. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen. Vaccine. 2010;28:7556–62.PubMedPubMedCentralCrossRef
32.
go back to reference Saenz R, Futalan D, Leutenez L, Eekhout F, Fecteau JF, Sundelius S, Larsson M, Hayashi T, Minev B, Carson D, Esener S, Messmer B, Messmer D. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med. 2014;12:211.PubMedPubMedCentralCrossRef Saenz R, Futalan D, Leutenez L, Eekhout F, Fecteau JF, Sundelius S, Larsson M, Hayashi T, Minev B, Carson D, Esener S, Messmer B, Messmer D. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med. 2014;12:211.PubMedPubMedCentralCrossRef
33.
go back to reference Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5:1–17. Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5:1–17.
34.
go back to reference Aghakhani A, Mamishi S, Sabeti S, Bidari-Zerehpoosh F, Banifazl M, Bavand A, Ramezani A. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran. Iran Med Microbiol Immunol. 2017;206:105–10.PubMedCrossRef Aghakhani A, Mamishi S, Sabeti S, Bidari-Zerehpoosh F, Banifazl M, Bavand A, Ramezani A. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran. Iran Med Microbiol Immunol. 2017;206:105–10.PubMedCrossRef
36.
go back to reference Kreimer AR, Clifford GM, Snijders PJF, Castellsague X, Meijer CJLM, Pawlita M, Viscidi R, Herrero R, Franceschi S. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer. 2005;115:329–32.PubMedCrossRef Kreimer AR, Clifford GM, Snijders PJF, Castellsague X, Meijer CJLM, Pawlita M, Viscidi R, Herrero R, Franceschi S. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer. 2005;115:329–32.PubMedCrossRef
37.
go back to reference Brown CA, Bogers J, Sahebali S, Depuydt CE, De Prins F, Malinowski DP. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. Hindawi Publishing Corporation, Journal of Oncology. 2012;2012:1–11. Brown CA, Bogers J, Sahebali S, Depuydt CE, De Prins F, Malinowski DP. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. Hindawi Publishing Corporation, Journal of Oncology. 2012;2012:1–11.
38.
go back to reference Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol. 2011;6(9):1083–98.PubMedCrossRef Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol. 2011;6(9):1083–98.PubMedCrossRef
39.
go back to reference Gutiérrez-Xicoténcat L, Plett-Torres T, Madrid-González CL, Madrid-Marina V. Molecular diagnosis of human papillomavirus in the development of cervical cancer. Salud Publica Mex. 2009;51(3):S479–88.CrossRef Gutiérrez-Xicoténcat L, Plett-Torres T, Madrid-González CL, Madrid-Marina V. Molecular diagnosis of human papillomavirus in the development of cervical cancer. Salud Publica Mex. 2009;51(3):S479–88.CrossRef
40.
go back to reference Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Muñoz N, Gissmann L, Shah KV. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology. 1992;187(2):508–14.PubMedCrossRef Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Muñoz N, Gissmann L, Shah KV. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology. 1992;187(2):508–14.PubMedCrossRef
41.
go back to reference Kim JH, Cho IH, Seo SM, Kim JS, Oh KH, Kang HS, Kim IG, Paek SH. Immuno-chromatographic analysis for HPV-16 and 18 E7 proteins as a biomarker of cervical cancer caused by human papillomavirus. Bull Kor Chem Soc. 2009;30(12):2999–3005.CrossRef Kim JH, Cho IH, Seo SM, Kim JS, Oh KH, Kang HS, Kim IG, Paek SH. Immuno-chromatographic analysis for HPV-16 and 18 E7 proteins as a biomarker of cervical cancer caused by human papillomavirus. Bull Kor Chem Soc. 2009;30(12):2999–3005.CrossRef
42.
go back to reference Metzger C, Pittl A, Kaufmann AM, Agorastos T, Chatzistamatiou K, Böcher O. A new sandwich ELISA test simultaneously detecting E7 proteins of HPV-16, 18 and 45 in cervical smears. Clin Microbiol. 2016;5:1–6.CrossRef Metzger C, Pittl A, Kaufmann AM, Agorastos T, Chatzistamatiou K, Böcher O. A new sandwich ELISA test simultaneously detecting E7 proteins of HPV-16, 18 and 45 in cervical smears. Clin Microbiol. 2016;5:1–6.CrossRef
43.
go back to reference Gariglio P, Organista-Nava J, Alvarez-Rios E. Role of HR-HPVs E6 and E7 oncoproteins in cervical carcinogenesis. J Mol Genet Med. 2005;10(2):1–11. Gariglio P, Organista-Nava J, Alvarez-Rios E. Role of HR-HPVs E6 and E7 oncoproteins in cervical carcinogenesis. J Mol Genet Med. 2005;10(2):1–11.
44.
go back to reference Meschede H, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, Gissmann L, Pawlita M. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol. 1998;36(2):475–80.PubMedPubMedCentral Meschede H, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, Gissmann L, Pawlita M. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol. 1998;36(2):475–80.PubMedPubMedCentral
45.
go back to reference Seigneuric R, Mjahed H, Gobbo J, Joly AL, Berthenet K, Shirley S, Garrido C. Heat shock proteins as danger signals for cancer detection. Front Oncol. 2011;1:1–10.CrossRef Seigneuric R, Mjahed H, Gobbo J, Joly AL, Berthenet K, Shirley S, Garrido C. Heat shock proteins as danger signals for cancer detection. Front Oncol. 2011;1:1–10.CrossRef
46.
go back to reference Gunaldi M, Kocoglu H, Okuturlar Y, Gedikbasi A, Karabulut M, Alis H, Hursitoglu M. Heat shock protein 70 is a useful marker for predicting colorectal cancer. JBUON. 2015;20(6):1464–70.PubMed Gunaldi M, Kocoglu H, Okuturlar Y, Gedikbasi A, Karabulut M, Alis H, Hursitoglu M. Heat shock protein 70 is a useful marker for predicting colorectal cancer. JBUON. 2015;20(6):1464–70.PubMed
47.
go back to reference Shan N, Zhou W, Zhang S, Zhang Y. Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis. Onco Targets Ther. 2016;9:2169–79.PubMedPubMedCentral Shan N, Zhou W, Zhang S, Zhang Y. Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis. Onco Targets Ther. 2016;9:2169–79.PubMedPubMedCentral
48.
go back to reference Khan R, Siddiqui NN, Haq A, Rahman MA. Introducing differential expression of human heat shock protein 27 in hepatocellular carcinoma: moving toward identification of cancer biomarker. Tumor Biol. 2016;37:715–21.CrossRef Khan R, Siddiqui NN, Haq A, Rahman MA. Introducing differential expression of human heat shock protein 27 in hepatocellular carcinoma: moving toward identification of cancer biomarker. Tumor Biol. 2016;37:715–21.CrossRef
49.
go back to reference Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, Park BK, Kalirai H, Dodson A, Azadeh B, Terlizzo M, Grabsch H, Mueller W, Myint S, Clark P, Wong H, Greenhalf W, Neoptolemos JP, Rooney PS, Costello E. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut. 2010;59:1501–10.PubMedCrossRef Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, Park BK, Kalirai H, Dodson A, Azadeh B, Terlizzo M, Grabsch H, Mueller W, Myint S, Clark P, Wong H, Greenhalf W, Neoptolemos JP, Rooney PS, Costello E. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut. 2010;59:1501–10.PubMedCrossRef
50.
go back to reference Kang SH, Kang KW, Kim KH, Kwon B, Kim SK, Lee HY, Kong SY, Lee ES, Jang SG, Yoo BC. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer. 2008;8:286.PubMedPubMedCentralCrossRef Kang SH, Kang KW, Kim KH, Kwon B, Kim SK, Lee HY, Kong SY, Lee ES, Jang SG, Yoo BC. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer. 2008;8:286.PubMedPubMedCentralCrossRef
51.
go back to reference Paricharttanakul NM, Saharat K, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J. Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas. Oncol Rep. 2016;5:2286–96.CrossRef Paricharttanakul NM, Saharat K, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J. Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas. Oncol Rep. 2016;5:2286–96.CrossRef
52.
go back to reference Okuno M, Adachi S, Kozawa O, Shimizu M, Yasuda I. The clinical significance of phosphorylated heat shock protein 27 (HSPB1) in pancreatic cancer. Int J Mol Sci. 2016;17(137):1–7. Okuno M, Adachi S, Kozawa O, Shimizu M, Yasuda I. The clinical significance of phosphorylated heat shock protein 27 (HSPB1) in pancreatic cancer. Int J Mol Sci. 2016;17(137):1–7.
53.
go back to reference Korneeva I, Caputo TA, Witkin SS. Cell-free 27 kDa heat shock protein (HSP27) and HSP27-cytochrome C complexes in the cervix of women with ovarian or endometrial cancer. Int J Cancer. 2002;102:483–6.PubMedCrossRef Korneeva I, Caputo TA, Witkin SS. Cell-free 27 kDa heat shock protein (HSP27) and HSP27-cytochrome C complexes in the cervix of women with ovarian or endometrial cancer. Int J Cancer. 2002;102:483–6.PubMedCrossRef
54.
go back to reference Ghayour-Mobarhan M, Saber H, Ferns GA. The potential role of heat shock protein 27 in cardiovascular disease. Clin Chim Acta. 2012;413:15–24.PubMedCrossRef Ghayour-Mobarhan M, Saber H, Ferns GA. The potential role of heat shock protein 27 in cardiovascular disease. Clin Chim Acta. 2012;413:15–24.PubMedCrossRef
55.
go back to reference Martin-Ventura JL, Duran MC, Blanco-Colio LM, Meilhac O, Leclercq A, Michel JB, Jensen ON, Hernandez-Merida S, Tunon J, Vivanco F, Egido J. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation. 2004;110:2216–9.PubMedCrossRef Martin-Ventura JL, Duran MC, Blanco-Colio LM, Meilhac O, Leclercq A, Michel JB, Jensen ON, Hernandez-Merida S, Tunon J, Vivanco F, Egido J. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation. 2004;110:2216–9.PubMedCrossRef
56.
go back to reference Rus KR, Fajs L, Korva M, Avsic-Zupanc T. HMGB1 is a potential biomarker for severe viral hemorrhagic fevers. PLoS Negl Trop Dis. 2016;10(6):e0004804.CrossRef Rus KR, Fajs L, Korva M, Avsic-Zupanc T. HMGB1 is a potential biomarker for severe viral hemorrhagic fevers. PLoS Negl Trop Dis. 2016;10(6):e0004804.CrossRef
57.
go back to reference Lee H, Song M, Shin N, Shin CH, Min BS, Kim HS, Yoo JS, Kim H. Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One. 2012;7(4):e34318.PubMedPubMedCentralCrossRef Lee H, Song M, Shin N, Shin CH, Min BS, Kim HS, Yoo JS, Kim H. Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One. 2012;7(4):e34318.PubMedPubMedCentralCrossRef
58.
Metadata
Title
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women
Authors
Amitis Ramezani
Arezoo Aghakhani
Sepehr Soleymani
Anahita Bavand
Azam Bolhassani
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3780-2

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue